InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,599.30
(
0.49%
)
US TECH 100
19,028.40
(
-0.25%
)
Dow Jones
41,350.93
(
-0.20%
)
Brent Oil
70.46
(
-0.33%
)
Bitcoin
82,799.55
(
-1.05%
)
Post# of 104
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 466
Posts 26951
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: surf1944 post# 67

Thursday, 10/13/2011 9:32:57 AM

Thursday, October 13, 2011 9:32:57 AM

Post# of 104
6:53AM China Medical Tech receives SFDA approval for its PCR-based KRAS Assay for colorectal cancer targeted drug (CMED) 4.93 : Co announced that China's State Food and Drug Administration has approved the Company's real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog assay as a companion diagnostic test for the use of a targeted drug for the treatment of colorectal cancer patients.


surf's up......crikey



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up